Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Research perspectives in inherited lymphatic disease.

Identifieur interne : 000C07 ( Ncbi/Curation ); précédent : 000C06; suivant : 000C08

Research perspectives in inherited lymphatic disease.

Auteurs : Robert E. Ferrell [États-Unis]

Source :

RBID : pubmed:12543715

Descripteurs français

English descriptors

Abstract

The hereditary lymphedemas provide an opportunity to identify genes involved in normal and deranged lymphatic development. Genetic analysis of families with Milroy's disease identified mutations in VEGFR3 as a cause of congenital lymphedema, confirming the importance of VEGFC/VEGFR3 signaling in lymphatic development. These observations led to the identification of a mouse model for primary lymphedema, and subsequent analysis of this mouse model, using transgenic and gene transfer techniques, has provided initial clues to the development of a biologically based therapy for primary lymphedema. Of more importance from a public health perspective is the fact that manipulation of this pathway may lead to effective therapies for the more prevalent forms of secondary lymphedema. Identification of FOXC2 as the gene mutated in the lymphedema-distichiasis syndrome has revealed new molecular insight into lymphatic development. Molecular analysis of the FOXC2 pathway may provide clues to developmental pathways shared by the lymphatic system and the other developmental abnormalities associated with this complex syndrome. With improving knowledge of the human genome, genetic analysis of families with lymphedema continues to offer one of the most promising approaches to identifying genes influencing lymphatic development.

PubMed: 12543715

Links toward previous steps (curation, corpus...)

Links to Exploration step

pubmed:12543715

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Research perspectives in inherited lymphatic disease.</title>
<author>
<name sortKey="Ferrell, Robert E" sort="Ferrell, Robert E" uniqKey="Ferrell R" first="Robert E" last="Ferrell">Robert E. Ferrell</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA. rferrell@mail.hgen.pitt.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261</wicri:regionArea>
<orgName type="university">Université de Pittsburgh</orgName>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12543715</idno>
<idno type="pmid">12543715</idno>
<idno type="wicri:Area/PubMed/Corpus">004392</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004392</idno>
<idno type="wicri:Area/PubMed/Curation">004392</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004392</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004392</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004392</idno>
<idno type="wicri:Area/Ncbi/Merge">000C07</idno>
<idno type="wicri:Area/Ncbi/Curation">000C07</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Research perspectives in inherited lymphatic disease.</title>
<author>
<name sortKey="Ferrell, Robert E" sort="Ferrell, Robert E" uniqKey="Ferrell R" first="Robert E" last="Ferrell">Robert E. Ferrell</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA. rferrell@mail.hgen.pitt.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261</wicri:regionArea>
<orgName type="university">Université de Pittsburgh</orgName>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Annals of the New York Academy of Sciences</title>
<idno type="ISSN">0077-8923</idno>
<imprint>
<date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>DNA-Binding Proteins (genetics)</term>
<term>Endothelial Growth Factors (genetics)</term>
<term>Forkhead Transcription Factors</term>
<term>Humans</term>
<term>Lymphatic Diseases (genetics)</term>
<term>Lymphedema (genetics)</term>
<term>Noonan Syndrome (genetics)</term>
<term>Research (trends)</term>
<term>Syndrome</term>
<term>Transcription Factors (genetics)</term>
<term>Vascular Endothelial Growth Factor C</term>
<term>Vascular Endothelial Growth Factor Receptor-3 (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Facteur de croissance endothéliale vasculaire de type C</term>
<term>Facteurs de croissance endothéliale (génétique)</term>
<term>Facteurs de transcription (génétique)</term>
<term>Facteurs de transcription Forkhead</term>
<term>Humains</term>
<term>Lymphoedème (génétique)</term>
<term>Maladies lymphatiques (génétique)</term>
<term>Protéines de liaison à l'ADN (génétique)</term>
<term>Recherche (tendances)</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire (génétique)</term>
<term>Syndrome</term>
<term>Syndrome de Noonan (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>DNA-Binding Proteins</term>
<term>Endothelial Growth Factors</term>
<term>Transcription Factors</term>
<term>Vascular Endothelial Growth Factor Receptor-3</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Forkhead Transcription Factors</term>
<term>Vascular Endothelial Growth Factor C</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Lymphatic Diseases</term>
<term>Lymphedema</term>
<term>Noonan Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Facteurs de croissance endothéliale</term>
<term>Facteurs de transcription</term>
<term>Lymphoedème</term>
<term>Maladies lymphatiques</term>
<term>Protéines de liaison à l'ADN</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire</term>
<term>Syndrome de Noonan</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr">
<term>Recherche</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en">
<term>Research</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Facteur de croissance endothéliale vasculaire de type C</term>
<term>Facteurs de transcription Forkhead</term>
<term>Humains</term>
<term>Syndrome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The hereditary lymphedemas provide an opportunity to identify genes involved in normal and deranged lymphatic development. Genetic analysis of families with Milroy's disease identified mutations in VEGFR3 as a cause of congenital lymphedema, confirming the importance of VEGFC/VEGFR3 signaling in lymphatic development. These observations led to the identification of a mouse model for primary lymphedema, and subsequent analysis of this mouse model, using transgenic and gene transfer techniques, has provided initial clues to the development of a biologically based therapy for primary lymphedema. Of more importance from a public health perspective is the fact that manipulation of this pathway may lead to effective therapies for the more prevalent forms of secondary lymphedema. Identification of FOXC2 as the gene mutated in the lymphedema-distichiasis syndrome has revealed new molecular insight into lymphatic development. Molecular analysis of the FOXC2 pathway may provide clues to developmental pathways shared by the lymphatic system and the other developmental abnormalities associated with this complex syndrome. With improving knowledge of the human genome, genetic analysis of families with lymphedema continues to offer one of the most promising approaches to identifying genes influencing lymphatic development.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C07 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000C07 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:12543715
   |texte=   Research perspectives in inherited lymphatic disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:12543715" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024